Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Apr;28(2):224-9.
doi: 10.1053/j.jvca.2013.10.026. Epub 2014 Jan 23.

Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass

Affiliations
Randomized Controlled Trial

Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass

Andrew Ian Levin et al. J Cardiothorac Vasc Anesth. 2014 Apr.

Abstract

Objective: The present study is a comparison of two point-of-care (POC) tests as endpoints of protamine titration after CPB. The authors hypothesized that using the heparinase-kaolin thromboelastography (TEG-HK) R-time difference would more readily identify residual heparin necessitating additional protamine than when using activated coagulation time (ACT). The primary endpoint was the between-group difference in protamine dose. Whether this approach would lessen postoperative bleeding and sequelae also was investigated.

Design: Single center, blinded, prospective, randomized study.

Setting: University teaching hospital.

Participants: Eighty-two adult patients for on-pump coronary artery bypass and/or valve surgery.

Interventions: Patients were randomized. In the ACT group, protamine was titrated until ACT did not exceed baseline by more than 10%. In the TEG group, a TEG-HK R-time difference less than 20% was targeted. Protamine was repeated to achieve the endpoints. Clinicians in the ACT group were blinded to TEG data and vice versa.

Measurements and main results: There was no between-group difference in total protamine dose (3.9 ± 0.6 and 4.2 ± 0.7; 95% CI of the difference between means: -0.544 to 0.008 mg/kg; p = 0.057) or protamine:heparin ratios (1.3:1 and 1.4:1; 95% CI of the difference between means: -0.05 to 0.03 mg/mg; p = 0.653). In the ACT group, 17% of patients required a second protamine dose, and in the TEG group, 24% of patients required a second protamine dose. No between-group differences in the postoperative transfusion requirements or intensive care unit length of stay were demonstrated.

Conclusion: No difference was identified in protamine dosing using either ACT or TEG-HK R-time difference as endpoints. Heparinase TEG may be useful for monitoring heparin reversal.

Keywords: activated coagulation time; cardiopulmonary bypass; heparin; heparinase; point-of-care test; postoperative bleeding; protamine; thromboelastography.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources